Dose Adjusted EPOCH
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dose Adjusted EPOCH, covering 2024-06-11 to 2024-06-11. Get the full timeline:
Most recent: Clinical Trial Update: Dose Adjusted EPOCH Regimen in Combination With Ofatumumab or Rituximab in Treating Patients With Newly Diagnosed or Relapsed or Refractory Burkitt Lymphoma or Relapsed or Refractory Acute Lymphoblastic Leukemia [Phase 2]